Mode
Text Size
Log in / Sign up
N/A Completed N=35 Randomized Treatment

Visual Function and Patient Satisfaction After Bilateral Implantation of AcrySof Natural ReSTOR (Model SN60D3) or AcrySof Natural Monofocal (Model SN60AT)

Source: ClinicalTrials.gov NCT00759668 ↗
Enrolled (actual)
35
Serious AEs
1.5%
Results posted
Jan 2011
Primary outcomePrimary: Near Best Corrected Visual Acuity (BCVA) - Binocular — 87.5; 100 Percentage of Participants

Summary

The purpose of the study is: * to compare visual parameters (Subjective refraction and Visual Acuity (VA)) and safety (tilt, decentration and posterior chamber opacification (PCO)) in a prospective series of 40 patients after bilateral implantation of AcrySof Natural ReSTOR (Model SN60D3) or AcrySof Natural Monofocal (Model SN60AT) * to assess patient satisfaction before and after implant

Outcome Measures

OutcomeResultp-value
PRIMARY
Near Best Corrected Visual Acuity (BCVA) - Binocular
87.5; 100 —
PRIMARY
Near Uncorrected Visual Acuity (UCVA) Binocular
100; 31.25 —
PRIMARY
Near Best Corrected Visual Acuity Left Eye (BCVA LE)
87.5; 100 —
PRIMARY
Near Uncorrected Visual Acuity Left Eye (UCVA LE)
100; 18.75 —
PRIMARY
Near Best Corrected Visual Acuity Right Eye (BCVA RE)
68.75; 100 —
PRIMARY
Near Uncorrected Visual Acuity Right Eye (UCVA RE)
100; 25 —

Eligibility Criteria

Inclusion:

  • Written informed consent
  • Age: ≥ 50 years ≤ 75 years
  • Bilateral age related cataract, to be extracted and followed by the implantation of Posterior Chamber Intraocular Lenses (IOLs)
  • Pre-operative and post-operative astigmatism ≤ 1 Diopter (D), as from Keratometry readings
  • Potential post operative Visual Acuity (VA) ≥ 20/40
  • Second eye surgery to take place no longer than 45 days after the first implant

Exclusion:

  • Irregular optical aberrations;
  • Pupil diameter in scotopic conditions more than 6 mm
  • Degenerative visual pathologies (ex: Age-related Macular Degeneration (AMD))
  • Other exclusions as from ReSTOR Directions for Use (DFU)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00759668). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search